Diagnostics

A new partnership integrates expert rater training with eCOA tech, aiming to reduce costly data errors and accelerate development of new neurological drugs.

A new AI platform is the first to get EU approval for predicting fertility treatment timing, promising to boost success rates and ease clinic workloads.

Aetrex and Tradehome Shoes will provide free 3D foot scans and custom orthotics to thousands of athletes at the 2026 Special Olympics USA Games.

TEDCO's latest funding round seeds 13 university-born ventures, tackling everything from hereditary hearing loss and cancer to environmental monitoring.

A CEO's personal battle with prostate cancer inspired a community golf tournament that is now on the verge of raising $1 million for critical research.

Scientists have created the first continent-wide map of bird flu's spread, explaining human cases and assessing the risk of a future pandemic.

At a major oncology conference, Zephyr AI will showcase AI that predicts patient response to targeted therapies, aiming to personalize cancer treatment.

A first-in-class AI software, neuropacs™, gains FDA clearance, promising to help doctors differentiate complex Parkinsonian syndromes with high accuracy.

C-mo Medical Solutions has received European approval for its AI-powered wearable, a device poised to transform respiratory care with objective, private data.

OncoHost's new research shows a patient's "biological age" can predict immunotherapy success, a potential breakthrough in personalized oncology.

Atelerix's revolutionary hydrogel eliminates the need for cold chain logistics, partnering with JH Health to unlock the booming Saudi biotech market.

A new fund, led by a lung cancer survivor and top radiologists, seeks to overhaul screening guidelines that currently miss thousands of at-risk patients.

Surpassing 50 studios with 100 more on the way, The Tox is dominating the noninvasive beauty space. Here’s how its unique franchise model is expanding.

New NCCN guidelines include AI mammogram analysis, a major shift to identify hidden breast cancer risks for millions of women missed by traditional methods.

A son's concern for his mother sparks an investment in a startup using AI to combat the hidden dangers of chronic dehydration affecting millions.

Oxford spinout Caristo Diagnostics appoints Stephen Deitsch, who led a $1.5B exit, as CEO to accelerate its mission of preventing heart attacks with AI.

BioTesserae's BTC-001, a novel immunotherapy, proves safe in early trials, paving the way for more affordable and accessible treatment for dogs.

As Ontario hospitals face a financial crisis, a major innovation week aims to connect Canadian startups with global capital to solve healthcare's biggest challenges.

FDA approves the first generic of a vital nutrition drug, granting Apotex a 180-day exclusive edge and signaling major cost savings for healthcare.

As scientific innovation in oncology accelerates, a new bottleneck emerges: bringing discoveries to market. Specialized firms are now crucial guides.